The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans
Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
New medical and wellness centre combines on-site care with telehealth to support industrial workforce and surrounding communities
Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market
The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031
Subscribe To Our Newsletter & Stay Updated
